Abbott

Abbott is one of the most broadly diversified healthcare companies in the world, operating across diagnostics, medical devices, nutritional products, and established pharmaceuticals. Founded in 1888 by physician Wallace Calvin Abbott in Chicago, the company has grown over more than a century into a global enterprise with operations in more than 160 countries and products used by hundreds of millions of people every day.

Diagnostics & Point-of-Care Innovation

Abbott's diagnostics division is among the largest in the industry, encompassing laboratory systems, rapid testing platforms, and molecular diagnostics. The company's point-of-care testing portfolio gained widespread recognition during the COVID-19 pandemic, when its BinaxNOW rapid antigen tests became one of the most widely deployed diagnostic tools globally. Its Alinity family of laboratory instruments serves hospitals and reference labs across multiple testing disciplines, including immunoassay, clinical chemistry, haematology, and molecular analysis.

Cardiovascular & Neuromodulation Devices

The medical devices segment, which Abbott significantly expanded through its 2017 acquisition of St. Jude Medical, covers cardiovascular and neuromodulation technologies. Products include electrophysiology catheters, cardiac rhythm management devices, structural heart solutions, and the Libre family of continuous glucose monitoring systems. FreeStyle Libre has become one of the most widely adopted continuous glucose monitors worldwide, transforming diabetes management for patients across dozens of markets.

Abbott's nutrition business, operating under brands including Ensure and Similac, serves both adult and paediatric markets globally. Its established pharmaceuticals division focuses on branded generics, primarily serving emerging markets where access to quality medicines at affordable price points is a priority.

Headquartered in Abbott Park, Illinois, Abbott is listed on the New York Stock Exchange under the ticker ABT and is a long-standing component of the S&P 500. The company's research and manufacturing footprint spans facilities across the United States, Europe, Asia-Pacific, and Latin America.

Further information is available at abbott.com.